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Abstract
Background: Aging is accompanied by decreasing general function in the cells and
tissues. D-galactose (D-gal) induces aging and plays a role in the pathogenesis of it.
Myricitrin is a plant-derived antioxidant.
Objective: The present study was performed to evaluate the effects of myricitrin
on antioxidant defense, sex hormone levels, uterus, and ovarian histology in D-gal-
induced aging female mouse model.
Materials and Methods: In this experimental study, 72 female adult NMRI mice,
weighing 30-35 gr, 3-4 months old, were randomly divided into six groups (n = 12/each):
(I) Control (vehicle; normal saline), (II) D-gal at 500 mg/kg/d for 45 days, (III-V) D-gal +
myricitrin-treated groups (these groups received myricitrin at 5, 10, and 20 mg/kg/d,
and (VI) D-gal + 100 mg/kg/d vitamin E orally for the last 28 days. The antioxidant
indices were done on the basis of colorimetric method, and sex hormone levels were
measured by using enzyme-linked immunosorbent assay kits. Histological assessment
of the uterus and ovaries were also evaluated.
Results: D-gal impaired the estrous cycle, also degenerative changes occur in the
ovarian follicles and damage to the uterus and ovarian tissue occurs. In D-gal group,
the level of sex hormones (p = 0.03) and the total antioxidant capacity (p = 0.002)
decreased, while the level of malondialdehyde and gonadotropins increased (p = 0.03).
Myricitrin at lower doses and vitamin E ameliorated the D-gal effects.
Conclusion: These findings suggest that myricitrin at low doses can effectively prevent
D-gal-induced oxidation and aging in mice. The effect of myricitrin was equivalent and
sometimes better than vitamin E.
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1. Introduction
Disturbance in antioxidant systems may lead
to pathological outcomes in women. An antiox-
idant supplement has been shown as a plan
for treating reproductive and infertility diseases
with oxidative stress control (1). The accelerated
aging of D-galactose (D-gal) in mice has been
widely used to study aging mechanisms and
drug screening (2). This model has a shorter life
span and aging features. Regular injection of D-
gal solution into the rat can be a sign of the
natural aging models used in the screening of
anti-aging drugs and their drug activities (3). D-
gal causes to weaken the immune system; a defi-
ciency in sex hormones; an increment in reactive
oxygen species (ROS), malondialdehyde (MDA),
and declined superoxide dismutase, catalase func-
tion, and the level of inflammatory cytokines
(4).
Health depends on the balance between free
radicals and antioxidant defense. Aging and age-
related illnesses are reflected as an inadequate
antioxidant defense for the body to deal with oxida-
tive stress during the time. Free radical/oxidative
stress theory states that because of themisbalance
of free radical metabolism, the structure and func-
tion of tissues and organs decrease and accelerate
aging (5).
D-gal plays a role as a reducing natural sugar
that reacts with amino groups in biomolecules (6,
7). Myricitrin, a flavonol glycoside, is plenty in the
fruits, branches, bark, and leaves of plants like
Myrica cerifera and Ampelopsis Eugenia uniflora
(8). Myricitrin -due to its high antioxidative, antiviral
and antibactericidal properties- is widley used in
foods, cosmetics, and medicines (6). The most
reported effects of myricitrin are antinociceptive,
anti-inflammatory, anti-allodynia, neuroprotective
and antioxidative properties (8). The protective
effects of myricitrin in endothelial cells against
ROS-induced apoptosis and atherosclerosis
formation in ApoE/mice have been reported (9). In
vitro studies have been shown effects of myricitrin
including anticarcinogenic, antinociceptive,
reduced oxidative stress, cytotoxicity in some
tissues and cells (6), production of antioxidant,
antidiabetic and antiapoptotic effects (10). Myricitrin
is a phytochemical agent that regulates fertility
with the ability to protect DNA from cell damaged
by oxidative stress (11).
Considering the antioxidant activity of myric-
itrin and the effects of D-gal to induce an
aging model of the animal through excessive
production of ROS and an antioxidant deficiency
and the effects of free radicals on the repro-
ductive system, this experimental study investi-
gated the effects of myricitrin on the reproduc-
tive system of female mice in D-gal aging mod-
els.
2. Materials and Methods
2.1. Drugs
The reagents are as follows: Myricitrin, purity
98% (AvaChem Scientific, USA), D-gal (Merck,
Germany), progesterone, 50 mg\ml, (Iran hormone,
Iran), Estradiol, valerate, 10 mg\ml, (Aburaihan, Iran),
and vitamin E, (Osve, Iran).
2.2. Animals and experimental details
The experimental study on 72 female NMRI
mice, weighing 30-35 gr, 3-4 months old, were
obtained from the animal house of the Ahvaz
Jundishapur University of Medical Sciences
(AJUMS). The animals had free access to tap
water and food with a 12-hr light/dark cycle and
controlled temperature (22 ± 2°C) all over the
experiment. The mice were randomly distributed
into six groups (n = 12/each) as follows:
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I. Control group: Mice received subcutaneously
(s.c.) vehicle; normal saline for 45 days (0.1 ml).
II. D-gal group: Mice were injected D-gal (s.c.,
500 mg/kg/d for 45 days) (4).
III. Mice were injected D-gal and myricitrin (5
mg/kg/d; by gavage for the last 28 days).
IV. Mice were injected D-gal and myricitrin (10
mg/kg/d; by gavage for the last 28 days).
V. Mice were injected D-gal and myricitrin (20
mg/kg/d; by gavage for the last 28 days).
VI. Mice were injected D-gal and vitamin E (100
mg/kg/d; by gavage for the last 28 days) (12).
2.3. Estrous cycle
The cycle of rodent breeding is called the
estrous cycle, which is short and accurate. These
four stages include proestrus, estrus, metestrus,
and diestrus, and last for 4 to 5 days (13).
In the beginning of experiments to match the
estrous cycle in the mice, each mouse received
an intramuscular injection of 100 mg of estra-
diol valerate (dissolved in 0.2 mL olive oil). After
42 hr, 50 mg of progesterone was injected
intramuscularly (4). The stages of the estrous
period in each mouse were determined by exam-
ining vaginal smear. For this, vaginal sampling
was performed using a wet swab with nor-
mal saline. The smears were constant on slides
and stained with 1% aqueous methylene blue,
after which they were evaluated microscopi-
cally.
2.4. Analysis of tissue
The mice were weighed and anesthetized with
ketamine/xylazine. After the blood samples were
gathered from the heart and centrifuged, the
plasma was separated and kept at -70°C for
hormonal evaluations. The uterine and ovarian
tissues of each mouse were removed and organ
weight/body weight ratio was accounted. The
segments of uterus and ovary were fixed in 10%
formalin for histological studies.
2.5. Hormonal assessment
Enzyme-linked immunosorbent assay (ELISA)
kits were used for measuring levels of estro-
gen and progesterone (DiaMetra, Italy). Mouse
Follicle-stimulating hormone (FSH) and Luteinizing
hormone (LH) levels were evaluated using the
ELISA assay kits (Cusabio China Inc., Wuhan,
China). The sensitivity of estrogen, progesterone,
FSH and LH were 10 pg/mL, 0.05 ng/mL, 2.5
and 0.5 mIU/ml respectively. The detection range
FSH and LH were 4-140 and 2-75 mIU/ml, intra-
and interassay coefficient of variation was <
15%.
2.6. Antioxidant enzyme activities
The TAC concentration levels in the plasmawere
assessed using the ELISA assay kits (ZellBio GmbH,
Germany) in accordance with the manufacturer’s
instructions. The TAC concentration assays can be
used to determine the TAC concentration within
a range of 0.125-2 mM with 0.1 mM sensitivity,
intraassay CV < 3.4%, and interassay CV < 4.2%.
MDA assessment in uterine and ovarian tissues
was performed using ELISA assay kit (ZellBio
GmbH, Germany). The assay detects the MDA level
calorimetrically in a range of 0.78-50 µM with 0.1
µM sensitivity, intraassay CV 5.8%, and interassay
CV7.6%.
2.7. Histology assessments
In 10% formalin solution the mouse ovary
and uterus tissues were fixed. The tissues were
dehydrated in graded alcohol concentrations and
embedded in paraffin. Sections of 4-6 μm were
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collected and stained with hematoxylin & eosin
(H&E). Six microscopic H&E-stained slides per ani-
mal were assayed for the assessment of histologi-
cal variations (14).
2.8. Ethical consideration
All procedures involving animals were approved
by the Animals Committee of AJUMS, and
conducted in accordance with the guide
for the Care and Use of Laboratory Animals
(IR.AJUMS.REC.1395.639).
2.9. Statistical analysis
The results are expressed as the mean ±
standard error of the means. One-way ANOVA
followed by post-hoc Tukey test (SPSS version
15, Chicago, IL, USA) was used to evaluate the
differences between the different groups. A p-
value<0.05was considered statistically significant
in each group.
3. Results
3.1. Effects of myricitrin on estrous
cycle
D-gal impaired the estrous cycle such as aging.
The administration of myricitrin at 5 mg/kg for 28
days improved the impairment of the estrus cycle
in D-gal-treated mice.
3.2. Effects of myricitrin on the
histology of the ovarian and uterine
tissues and weight
A microscopic assessment by H&E
demonstrated that in the control group, the
ovaries included Graafian follicles with a clear
zona pellucida. In the D-gal-treated mice ovaries,
degenerative variations obtained in the follicles.
In the D-gal group the Graafian follicle and
zona pellucida were not evident. In the D-gal
+ 5 mg myricitrin group, Graafian follicle with
an obvious zona pellucida was observed. In
D-gal + 10 mg myricitrin group, the number of
growing follicles seemed to be less than D-gal +
5 mg Myricitrin. In the D-gal + 20 mg myricitrin
group follicular degeneration in different stages
was evident. In the D-gal + 100 mg vitamin E
group, growing follicles in different stages were
observed (Figure 1). The uterus of the control mice
had normal histological architecture. Atrophy of
the endometrium and decrease in the glands
number was observed in the D-gal group. In the
D-gal + 5 mg myricitrin group, the number of
glands and the height of endometrium seemed
to be more than the D-gal-treated mice. The
appearance of the uterus in both the D-gal + 10
mg myricitrin and the D-gal + 20 mg myricitrin
groups was similar to the D-gal-treated mice. The
architecture of the uterus in the D-gal + 100 mg
vitamin E groups was similar to the D-gal + 5 mg
myricitrin group (Figure 2). The ovary and uterus
weight/body weight percentage did not change
significantly in the intra-group comparison (Table
I).
3.3. Effects of myricitrin on the plasma
levels of sex hormones
The plasma level of estrogen in theD-gal-treated
mice was significantly lower than in the control
group (p = 0.03). Myricitrin significantly increased
the estrogen level in the D-gal + 5 mg (p = 0.02),
10, and 20 mg myricitrin (p < 0.001) compared
to the D-gal group. The effect of D-gal + 20
mg myricitrin on the estrogen level was similar
to the effect of D-gal + 100 mg vitamin E (Table
II).
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D-gal decreased the progesterone level com-
pared to the control group (p = 0.03). This level was
significantly increased in the D-gal + 5 (p = 0.02),
10 (p = 0.01), and 20 mg (p < 0.001) myricitrin and
Vitamin E groups (p = 0.003), compared to theD-gal
group (Table II).
The plasma level of LH was significantly
increased (p = 0.03) by treating the D-gal group
compared with the control group. Myricitrin 5 and
10 mg (p = 0.002) decreased this level significantly
in the D-gal-treated mice. The plasma level of FSH
was significantly increased (p = 0.03) by treating
the D-gal group compared with the control group.
Myricitrin 5mg and Vitamin E significantly (p = 0.04)
decreased this level in the D-gal-treated mice. The
plasma level of LH and FSH in D-gal-treated
mice received the highest dose of myricitrin and
were approximately equal to the D-gal group
(Table II).
3.4. Effects of myricitrin on the
antioxidant indices of ovarian and
uterine tissues
The plasma levels of MDA in the D-gal group
were significantly increased (p = 0.03) compared
to the control mice (Figure 3A), while TAC activity
in the D-gal group significantly decreased (p =
0.002) compared to the control group (Figure 3B).
Myricitrin significantly decreased the tissue level
of MDA and increased TAC. Myricitrin at 5 mg/kg
significantly decreased the MDA levels (p < 0.001)
and increased TAC (p = 0.04) in the D-gal mice
compared to the other doses of myricitrin and
vitamin E.
Table I. The effect of different doses of myricitrin and vitamin E on the ovary and uterus weight/body weight percentage in the
D-gal-treated mice (n = 12)
Groups Ovary and uterus/body weight (%)
Control 0.98 ± 0.12
D-gal 0.89 ± 0.07
D-gal + M5 0.82 ± 0.06
D-gal + M10 0.86 ± 0.05
D-gal + M20 0.96 ± 0.13
D-gal + E100 0.92 ± 0.03
Mean ± SE, one-way ANOVA, and post-hoc LSD tests
D-gal: D-galactose; D-gal + M: D-galactose+ Myricitrin; D-gal + E: D-galactose+ vitamin E
Table II. The effect of different doses of myricitrin and vitamin E on sex hormones in aging mice induced by D-gal (n = 12)
Groups LH (mlU/ml) FSH (mlU/ml)) Estrogen (pg/ml) Progesterone (ng/ml)
Control 0.71 ± 0.18 3.38 ± 0.99 485.25 ± 121.58 18.98 ± 0.85
D-gal 1.64 ± 0.12* 6.61 ± 0.67* 131.91 ± 64.39∗$$$ 17.40 ± 0.66*
D-gal + M5 0.67 ± 0.18##$$ 5.20 ± 0.76# 209.62 ± 85.06#$$ 20.97 ± 1.08#
D-gal + M10 0.82 ± 0.04##$$ 6.03 ± 0.57∗∗ 529.62 ± 119.08### 21.27 ± 2.61##
D-gal + M20 1.60 ± 0.20** 5.59 ± 0.65∗ 1049.05 ± 240.23### 36.61 ± 3.14###
D-gal + E100 1.49 ± 0.14∗∗##$$ 4.30 ± 0.40# 1016.50 ± 208.62###∗∗ 25.33 ± 3.29##
Mean ± SE, one-way ANOVA, and post-hoc LSD tests
*P < 0.05 and **p < 0.01 vs Control; #P < 0.05, ##p < 0.01, and ###p < 0.001 vs D-gal; $P < 0.05, $$p < 0.01, and $$$p < 0.001 vs
D-gal + M20
D-gal: D-galactose; D-gal + M: D-galactose+ Myricitrin; D-gal + E: D-galactose+ vitamin E; LH: Luteinizing hormone; FSH: Follicle
stimulating hormone
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Figure 1. Light microscopy of cross-sections of hematoxylin- and eosin-stained ovaries from the control and experimental groups:
(A) Control, (B) D-gal, (C) D-gal + 5 mg/kg myricitrin, (D) D-gal + 10 mg/kg myricitrin, (E) D-gal + 20 mg/kg myricitrin, and (F) D-gal
+ 100 mg/kg vitamin E. Scale bars: 100 µm.
 
 
A B C 
D E F 
Figure 2. Light microscopy of cross-sections of hematoxylin- and eosin-stained uterus from the control and experimental groups:
(A) control, (B) D-gal, (C) D-gal + 5 mg/kg myricitrin, (D) D-gal + 10 mg/kg myricitrin, (E) D-gal + 20 mg/kg myricitrin, and (F) D-gal
+ 100 mg/kg vitamin E. Scale bars: 50 µm.
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A B
Figure 3. Effect of myricitrin and vitamin E on (A) plasma MDA and (B) TAC level in D-gal-treated mice. Results are presented as
mean ± SEM; n = 12;∗p < 0.05 compared with the control group. ##p < 0.01 and ###p < 0.001 compared with the D-gal group, $$p
< 0.01 compared between the treated groups.
4. Discussion
This study revealed that myricitrin effectively
reduced the effects of aging caused by D-gal in
the female mice reproductive system. The D-gal-
induced aging model has been generally used for
aging research because it speeds up the aging
process that is similar to natural aging processes
(3). D-gal has been used to generate a natural-like
aging process and oxidative stress (15).
Previous studies have shown that D-gal can raise
the LH and FSH levels in male mice (16). A previous
study reported that D-gal can decrease estrogen
and progesterone levels (4). Consistent with the
previous report, the present study also indicated
that estrogen and progesterone levels decreased
and the levels of gonadotropins increased in the D-
gal group. The present study demonstrates that D-
gal could increase LH and FSH levels. The previous
study revealed that D-gal can increase LH and
FSH levels in male mice similar to the hormonal
changes in aging (16). Myricitrin at lower doses
decreased this level in D-gal-treated mice. The
plasma level of LH and FSH in D-gal-treated mice
received a high dose of myricitrin approximately
equal to the D-gal group. Therefore, these findings
show that myricitrin at 20 mg/kg was not able to
treat or alleviate the impairment effects of D-gal
on gonadotropins. Myricitrin at this dose could also
not improve the total antioxidant capacity, while
at low doses, the total antioxidant capacity can
be increased. Most studies confirm the role of
oxidative stress in the development of reproduc-
tive system diseases (16-18). Oxidative stress, the
imbalance between the production of ROS and
antioxidant defense, leads to various reproductive
diseases such as endometriosis and polycystic
ovarian syndrome (18).
Various antioxidant protective systems, includ-
ing vitamin E, CAT and glutathione, maintain the
reproductive system from ROS at physiological
levels. ROS at the pathologic level disrupts the
antioxidant defense and causes damage to the
reproductive system (17), while at the physiological
level, it plays an important role in the natural
reproduction process (19). Vitamin E was initially
found to be essential for reproduction, which is
found in a number of foods and herbs (20). In
this study, it was revealed that vitamin E protected
the function of ovaries against D-gal. In agreement
with this study, previous researches have shown
that vitamin E acts as a strong natural antioxidant,
especially in the reproductive system (21). Also
vitamin E deficiency has an adverse effect on
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fertility and pregnancy (22). Vitamin E as a potent
antioxidant improves reproductive disorders (23).
In this study, myricitrin has been shown to
increase estrogen concentration and effectively
reduce the effects of aging caused by D-gal.
High doses of myricitrin increased estrogen and
progesterone level, but gonadotropins could not
be reduced, hence, the hypothalamic-pituitary-
gonadal axis did not function properly. In other
words, the present findings indicate that a high
dose of myricitrin exerts effects on the hypotha-
lamic and/or the pituitary gland and cannot com-
pensate for the effect of D-gal on gonadotropin
hormones. Therefore, it is probable that myricitrin
cannot be useful at high concentrations for the
reproductive system.
In this study, D-gal has been responsible for lipid
peroxidation and thereby for increasing the content
of MDA, which is a chief sign of lipid peroxidation
in aging textures. On the contrary, D-gal reduces
the level of antioxidants, such as TAC, causing
oxidative damage. Similar to these results, D-gal
accelerates the aging process by decreasing TAC
and increasing MDA levels in the ovary (4). As
shown in the present results, myricitrin decreased
the MDA content while increasing the TAC activity.
Also, in another study, showed that, myricitrin can
reduce MDA contents (24). Then, D-gal causes
oxidative stress, which is consistent with Yan and
colleague’s study that showed that D-gal reduces
the number of follicles and oocytes, resulting in
aging of the ovary (25).
Kassem and co-workers for the first time showed
that natural myricitrin extracts protected cells and
DNA structure against oxidative stress by downreg-
ulating the gene expression of cytochrome P19 and
LH as well as by upregulating the gene expression
of glutathione S-transferase (11). In the previous
study, it has been shown that myricitrin prevented
oxidative stress and cell apoptosis caused by
hyperglycemia (24).
The present study also indicated that the ovary
and uterus weight/body weight percentage did not
change in the intragroup comparison. Perhaps the
uterus and ovary have grown in proportion to the
trend of weight gain (26). As the present results
implied, the inability of myricitrin at dose 20 mg/kg
against the deleterious effect of D-gal on ovaries
and uterus functions is due to a lack of antioxidant
activity at this dose. Therefore, these findings
strongly reveal that myricitrin through increasing
the antioxidant potency protected the ovaries and
uterus against D-gal in mice.
5. Conclusion
This research showed that D-gal by inducing
oxidative stress creates a model of aging similar
to the normal female reproductive system and
reduces fertility. Our results showed that myricitrin
in low doses can delay the aging process by
increasing secretion of estrogen and progesterone
levels, reducing LH, FSH, MDA content and increas-
ing TAC. Myricitrin also had a positive effect on
the tissues of the uterus and ovaries. Therefore,
myricitrin with the inhibitory effect of oxidative
stress in the agingmodel induced by D-gal, and the
suppression of free radicals and ROS, improved the
age-related changes in the reproductive system.
The minimal studied dose of myricitrin had the
highest level of protection compared to other
doses. Myricitrin at 20 mg/kg was not toxic but
failed to increase the antioxidant potency. These
findings suggest that myricitrin can be a candidate
to alleviate the age-related changes in women.
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